CATO Thought Leadership

CATO Thought Leadership

Webinar Thought Leadership Series:

  • New FDA Gudiances for February 2020 and Upcoming…
    by Cato Research on March 4, 2020 at 6:28 pm

    By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS    Special Interest Guidances/Information Date Posted Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus […]

  • What’s New Health Canada? January and February…
    by Cato Research on March 4, 2020 at 5:52 pm

      By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate   What’s New in:   Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: […]

  • New FDA Gudiances for January 2020 and Upcoming…
    by Cato Research on February 4, 2020 at 8:21 pm

    By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS Special Interest Guidances/Information Date Posted Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Draft […]

  • New FDA Guidances for November and December 2019…
    by Cato Research on January 6, 2020 at 9:36 pm

    By Alice Li, MD, MSc, RAC(CAN), Regulatory Scientist, Cato Research Special Interest Guidances/Information Date Posted Guidance for Industry: Serving Sizes of Foods That Can Reasonably Be Consumed At One Eating Occasion, Reference Amounts Customarily Consumed, Serving Size-Related Issues, […]

  • What’s New Health Canada? November 2019 Updates
    by Cato Research on December 20, 2019 at 2:41 pm

    By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate   What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: […]